May 10, 2017 Bio/Pharma/CRO

Roche provides update on phase III study of TECENTRIQ® (atezolizumab) in people with previously treated advanced bladder cancer

Basel, 10 May 2017 Roche provides update on phase III study of TECENTRIQ® (atezolizumab) in people with previously treated advanced bladder cancer IMvigor211 study did not meet its primary endpoint of overall survival (OS) compared to chemotherapy The safety profile was consistent with what has been previously observed for TECENTRIQ Roche (SIX: RO, ROG; OTCQX:... Read more

May 2, 2017 Bio/Pharma/CRO Liq. Handling & Robotics Product Launch

Unchained Labs rolls out Unfilter

PLEASANTON, Calif., May 2, 2017 /PRNewswire/ — Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, launched their new Unfilter today. The proprietary, 96-well ultrafiltration consumable is designed for use on the company’s one-of-a-kind, fully automated buffer exchange systems Freeslate and Junior. Unfilter gives researchers complete... Read more

April 26, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

New data at AAN reinforce clinical benefit of Roche's OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis

Basel, 26 April 2017 New data at AAN reinforce clinical benefit of Roche’s OCREVUS™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis OCREVUS rapidly suppressed signs of disease activity in relapsing MS (RMS) patients In patients with early RMS – recently diagnosed and without prior treatment – OCREVUS was superior to Rebif® (interferon beta-1a) in... Read more

April 25, 2017 Bio/Pharma/CRO Lab Top-10 M&A, Partnerships

MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups

News Release April 25, 2017 Your Contact: Karen Tiano  +1 978 495 0093 Billerica, Massachusetts, April 25, 2017 — MilliporeSigma announced today that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts. LabCentral is a private, non-profit organization that provides entrepreneurs and innovative life-sciences startups with lab space and... Read more

April 24, 2017 Bio/Pharma/CRO Clinical Research/Diagn. M&A, Partnerships

United BioPharma selects GE Healthcare’s FlexFactory to build late-stage clinical and commercial production capacity for biopharmaceuticals

CHALFONT ST. GILES, UK and HsinCHu, TAIWAN– 25 April 2017 – United BioPharma Inc. (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform to its new facility focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies in Hsinchu Industrial Park, Taiwan. With this added capacity, UBP will support local healthcare needs by bringing... Read more

April 20, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10

Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock

Thermo Fisher Scientific Inc. today announced that results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published in the May 2017 print issue of Critical Care Medicine. Researchers from the study, titled “Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study,” investigated the use of... Read more